医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2013年
7期
1302-1303,1306
,共3页
手足口病/药物疗法%干扰素α/投药和剂量
手足口病/藥物療法%榦擾素α/投藥和劑量
수족구병/약물요법%간우소α/투약화제량
Hand,Foot and Mouth Disease/DT%Interferon-alpha/AD
[目的]探讨干扰素α-1b治疗儿童手足口病的疗效及安全性。[方法]将189例儿童手足口病随机分为观察组98例,给予干扰素雾化吸入每日1次,对照组91例,给予静脉滴入病毒唑每日1次,疗程均为3 d。[结果]观察组的总有效率为93.88%,对照组为60.44%,两组比较差异有显著性( P <0.01)。观察组在退热时间,手足皮疹及口腔溃疡愈合方面均优于对照组( P <0.01),观察组未发现明显毒副作用。[结论]干扰素治疗儿童手足口病的疗效明显优于利巴韦林,值得临床上推广应用。
[目的]探討榦擾素α-1b治療兒童手足口病的療效及安全性。[方法]將189例兒童手足口病隨機分為觀察組98例,給予榦擾素霧化吸入每日1次,對照組91例,給予靜脈滴入病毒唑每日1次,療程均為3 d。[結果]觀察組的總有效率為93.88%,對照組為60.44%,兩組比較差異有顯著性( P <0.01)。觀察組在退熱時間,手足皮疹及口腔潰瘍愈閤方麵均優于對照組( P <0.01),觀察組未髮現明顯毒副作用。[結論]榦擾素治療兒童手足口病的療效明顯優于利巴韋林,值得臨床上推廣應用。
[목적]탐토간우소α-1b치료인동수족구병적료효급안전성。[방법]장189례인동수족구병수궤분위관찰조98례,급여간우소무화흡입매일1차,대조조91례,급여정맥적입병독서매일1차,료정균위3 d。[결과]관찰조적총유효솔위93.88%,대조조위60.44%,량조비교차이유현저성( P <0.01)。관찰조재퇴열시간,수족피진급구강궤양유합방면균우우대조조( P <0.01),관찰조미발현명현독부작용。[결론]간우소치료인동수족구병적료효명현우우리파위림,치득림상상추엄응용。
[Objective]To explore the efficacy and safety of interferonα-1b for the treatment of children with hand , foot and mouth disease .[Methods] Totally 189 children with hand ,foot and mouth disease were randomly divided into treatment group( n=98) and control group( n=91) .The treatment group was given interferonα-1b by atomized inhala-tion once daily ,while the control group was given ribavirin by intravenous injection once daily .The treatment course was 3 days .[Results]The total effective rate of treatment group and control group was 93 .88 % and 60 .44% respectively , and there were significant differences between two groups ( P<0 .01) .The time of temperature decreasing and the skim rash and mouth ulcer healing in treatment group were better than control group ( P<0 .01) .No obvious side effect was found in treatment group .[Conclusion]The efficacy of interferonα-1b for the treatment of children with hand ,foot and mouth disease is better than ribavirin .It is worthy of clinical promotion .